Accès gratuit
Med Sci (Paris)
Volume 28, Numéro 11, Novembre 2012
Page(s) 920 - 923
Section Nouvelles
Publié en ligne 12 novembre 2012
  1. Sultan A, Nesslany F, Violet M, et al. Nuclear tau, a key player in neuronal DNA protection. J Biol Chem 2011 ; 286 : 4566–4575. [CrossRef] [PubMed]
  2. Selkoe DJ. Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 2001 ; 81 : 741–766. [PubMed]
  3. Mawuenyega KG, Sigurdson W, Ovod V, et al. Decreased clearance of CNS beta-amyloid in Alzheimer’s disease. Science 2010 ; 330 : 1774. [CrossRef] [PubMed]
  4. Gosselet F, Candela P, Cecchelli R, et al. La barrière hémato-encéphalique. Une nouvelle cible thérapeutique dans la maladie d’Alzheimer ? Med Sci (Paris) 2011 ; 27 : 987–992. [CrossRef] [EDP Sciences] [PubMed]
  5. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008 ; 57 : 178–201. [CrossRef] [PubMed]
  6. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993 ; 90 : 1977–1981. [CrossRef]
  7. Bell RD, Winkler EA, Singh I, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 2012 ; 485 : 512–516. [PubMed]
  8. Nishitsuji K, Hosono T, Nakamura T, et al. Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model. J Biol Chem 2011 ; 286 : 17536–17542. [CrossRef] [PubMed]
  9. Vandenhaute E, Dehouck L, Boucau MC, et al. Modelling the neurovascular unit and the blood-brain barrier with the unique function of pericytes. Curr Neurovasc Res 2011 ; 8 : 258–269. [CrossRef] [PubMed]
  10. Saint-Pol J, Vandenhaute E, Boucau MC, et al. Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-beta peptide accumulation. J Alzheimers Dis 2012 ; 30 : 489–503. [PubMed]
  11. Boucher P, Gotthardt M, Li WP, et al. LRP: role in vascular wall integrity and protection from atherosclerosis. Science 2003 ; 300 : 329–332. [CrossRef] [PubMed]
  12. Cramer PE, Cirrito JR, Wesson DW, et al. ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 2012 ; 335 : 1503–1506. [CrossRef] [PubMed]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.